Probiotic Trial Data for Functional Constipation and Physical Well-being

78 adults with functional constipation participated in a randomized, double-blind, placebo-controlled trial over 4 weeks. The dataset likely contains outcomes measuring weekly spontaneous bowel movements, stool form, and physical functioning scores from the SF-36 survey. The data was authored by Hyung Gyu Park and published on figshare under a CC-BY-4.0 license.

Use Cases

• Analyze the efficacy of a specific probiotic blend based on changes in weekly spontaneous bowel movements.
• Compare stool consistency shifts between treatment groups based on Bristol stool type classifications.
• Evaluate improvements in physical well-being based on SF-36 physical functioning scores.
• Assess safety and symptom alleviation based on secondary outcomes like abdominal pain and incomplete evacuation.

Strengths

• Data originates from a randomized, double-blind, placebo-controlled trial, a rigorous study design.
• The trial included 78 participants, with 40 in the probiotic group and 38 in the placebo group.
• Primary and secondary outcomes are clearly defined, including WSBM, stool form, and SF-36 scores.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is 9.5 KB, indicating a very limited scope and likely summary-level data.

Provenance

Source

figshare

Collection Method

Data collected from a clinical trial registered with the Clinical Research Information Service (CRIS), KCT0010085.

Time Range

Trial duration was 4 weeks.

Freshness

Last updated 2026-04-24 17:43:19; freshness should be verified.